Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 13546
TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802289BDBM802289(N'-ethyl-4-(2-((3-fluoro-4- (morpholine-4- carbony...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802288BDBM802288(4-(5-chloro-2-((3-fluoro-4- (morpholine-4- carbony...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802290BDBM802290(N'-ethyl-4-(2-((4-(morpholine-4- carbonyl)phenyl)a...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802285BDBM802285(N-hydroxy-4-(2-(2-(2- methylmorpholino)acetamido) ...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802284BDBM802284(4-(2-((3-fluoro-4-(1-(2- methylmorpholino)ethyl)ph...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802287BDBM802287((R)-4-(2-((3-fluoro-4-((2- methylmorpholino)methyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802286BDBM802286((S)-4-(2-((3-fluoro-4-((2- methylmorpholino)methyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802296BDBM802296(4-(2-(2-oxa-7- azaspiro[3.5]nonan-7- yl)pyrimidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802297BDBM802297(N-hydroxy-4-(2-(2-oxo-1-oxa- 3,8-diazaspiro[4.5]de...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802292BDBM802292(N'-ethyl-4-(2- morpholinopyrimidin-4- yl)benzohydr...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802294BDBM802294(4-(2-(2-oxa-7- azaspiro[3.5]nonan-7- yl)pyrimidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802302BDBM802302((R)-4-(4-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802130BDBM802130(4-(2-((3-fluoro-4-(morpholine-4- carbonyl)phenyl)a...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802275BDBM802275(4-(2-((3-fluoro-4-(4- methylpiperazine-1- carbonyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802273BDBM802273(4-(2-((3-fluoro-4-(4- methylpiperidine-1- carbonyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802298BDBM802298(4-(2-(4,4-difluoropiperidin-1- yl)pyrimidin-4-yl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802300BDBM802300((S)-4-(4-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802281BDBM802281(4-(2-((3-fluoro-4-(1-(4- methylpiperazin-1- yl)eth...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802280BDBM802280(4-(2-((3-fluoro-4-((4-(oxetan-3- yl)piperazin-1- y...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802282BDBM802282(4-(2-((3-fluoro-4-(2- methylmorpholino)phenyl)amin...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802277BDBM802277(4-(2-((3-fluoro-4-((4- methylpiperidin-1- yl)methy...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802276BDBM802276(4-(2-((3-fluoro-4-(2- methylmorpholine-4- carbonyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802279BDBM802279(4-(2-((3-fluoro-4-((2- methylmorpholino)methyl)phe...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802278BDBM802278(4-(2-((3-fluoro-4-((4- methylpiperazin-1- yl)methy...)
Affinity DataIC50: 1.00E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802303BDBM802303((S)-4-(5-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802291BDBM802291(N-(4-(4-(2-ethylhydrazine-1- carbonyl)phenyl)pyrim...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802305BDBM802305((S)-N-(4-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802299BDBM802299((S)-4-(4-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802301BDBM802301((R)-4-(4-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802283BDBM802283(4-(2-((3-fluoro-4-(2- methylmorpholino)phenyl)amin...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802307BDBM802307((R)-4-(5-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802306BDBM802306((S)-4-(5-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802308BDBM802308(4-(5-(5-(difluoromethyl)-1,3,4- oxadiazol-2-yl)pyr...)
Affinity DataIC50: 5.50E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802304BDBM802304((R)-4-(5-(5-(difluoromethyl)- 1,3,4-oxadiazol-2-yl...)
Affinity DataIC50: 2.25E+4nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802136BDBM802136(N-cyano-4-(2-((3-fluoro-4- (morpholine-4- carbonyl...)
Affinity DataIC50: 1.00E+5nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802295BDBM802295(4-(5-chloro-2-(2-oxa-7- azaspiro[3.5]nonan-7- yl)p...)
Affinity DataIC50: 1.00E+5nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Baerenkraft Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 802293BDBM802293(4-(5-chloro-2- morpholinopyrimidin-4-yl)-N'- ethyl...)
Affinity DataIC50: 1.00E+5nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent